Abstract
Most essential functions are associated with various protein–protein interactions, particularly the cytokine–receptor interaction. Knowledge of the heterogeneous network of cytokine– receptor interactions provides insights into various human physiological functions. However, only a few studies are focused on the computational prediction of these interactions. In this study, we propose a novel machine-learning-based method for predicting cytokine–receptor interactions. A protein sequence is first transformed by incorporating the sequence evolutional information and then formulated with the following three aspects: (1) the k-skip-n-gram model, (2) physicochemical properties, and (3) local pseudo position-specific score matrix (local PsePSSM). The random forest classifier is subsequently employed to predict potential cytokine–receptor interactions. Experimental results on a dataset of Homo sapiens show that the proposed method exhibits improved performance, with 3.4% higher overall prediction accuracy, than existing methods.
Keywords: Cytokine–receptor interaction prediction, feature extraction, random forest, sequence evolutional information.
Combinatorial Chemistry & High Throughput Screening
Title:A novel machine learning method for cytokine-receptor interaction prediction
Volume: 19 Issue: 2
Author(s): Leyi Wei, Quan Zou, Minghong Liao, Huijuan Lu and Yuming Zhao
Affiliation:
Keywords: Cytokine–receptor interaction prediction, feature extraction, random forest, sequence evolutional information.
Abstract: Most essential functions are associated with various protein–protein interactions, particularly the cytokine–receptor interaction. Knowledge of the heterogeneous network of cytokine– receptor interactions provides insights into various human physiological functions. However, only a few studies are focused on the computational prediction of these interactions. In this study, we propose a novel machine-learning-based method for predicting cytokine–receptor interactions. A protein sequence is first transformed by incorporating the sequence evolutional information and then formulated with the following three aspects: (1) the k-skip-n-gram model, (2) physicochemical properties, and (3) local pseudo position-specific score matrix (local PsePSSM). The random forest classifier is subsequently employed to predict potential cytokine–receptor interactions. Experimental results on a dataset of Homo sapiens show that the proposed method exhibits improved performance, with 3.4% higher overall prediction accuracy, than existing methods.
Export Options
About this article
Cite this article as:
Wei Leyi, Zou Quan, Liao Minghong, Lu Huijuan and Zhao Yuming, A novel machine learning method for cytokine-receptor interaction prediction, Combinatorial Chemistry & High Throughput Screening 2016; 19 (2) . https://dx.doi.org/10.2174/1386207319666151110122621
DOI https://dx.doi.org/10.2174/1386207319666151110122621 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
Current Pharmaceutical Design The Treatment Targets of Asthma: From Laboratory to Clinic
Inflammation & Allergy - Drug Targets (Discontinued) Molecular and Biological Aspects of the Bovine Immunodeficiency Virus
Current HIV Research Exploring 1,3,4-Oxadiazole Scaffold for Anti-inflammatory and Analgesic Activities: A Review of Literature From 2005-2016
Mini-Reviews in Medicinal Chemistry Chemoprevention of Breast Cancer by Dietary Compounds
Anti-Cancer Agents in Medicinal Chemistry STAT3 as a Therapeutic Target for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Janus Kinase Inhibition with Tofacitinib: Changing the Face of Inflammatory Bowel Disease Treatment
Current Drug Targets Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Socioeconomic Status: The Missing Link Between Obesity and Diabetes Mellitus?
Current Diabetes Reviews Novel Targets and Derived Small Molecule Inhibitors in Multiple Myeloma
Current Cancer Drug Targets Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach
Current Pharmaceutical Design Lactones: Generic Inhibitors of Enzymes?
Mini-Reviews in Medicinal Chemistry Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam
Pharmaceutical Nanotechnology Expression Suppression and Activity Inhibition of TRPM7 Regulate Cytokine Production and Multiple Organ Dysfunction Syndrome During Endotoxemia: a New Target for Sepsis
Current Molecular Medicine In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib
Current Drug Delivery Development of Radioligands for the Imaging of α7 Nicotinic Acetylcholine Receptors with Positron Emission Tomography
Current Drug Targets Investigating Drug Repositioning Approach to Design Novel Prodrugs for Colon-specific Release of Fexofenadine for Ulcerative Colitis
Current Drug Delivery High Fat Intake, Inflammation and Risk of Neuropsychiatric Disorders
Current Immunology Reviews (Discontinued)